Skip to main content
. 2021 Mar 24;28:1073274821999655. doi: 10.1177/1073274821999655

Figure 4.

Figure 4.

(a) Cisplatin at 20 µM, 40 µM and 60 µM concentration, for 24 h inhibited cell viability of MIA PaCa-2 pancreatic cells dose-dependently, compared to CI values measured after treatment with 50 ppm D-concentration. (n = 3 +SD; *p < 0.05 in DDW treated cultures in comparison with 150 ppm and 50 ppm of D; #p < 0.05 in DDW treated cultures in comparison with 20 µM cisplatin). (b) Cisplatin at 20 µM concentration for 24 h inhibited cell viability of MIA PaCa-2 pancreatic cells dose-dependently after treatment with 105 ppm, 50 ppm and 25 ppm of D, compared to CI values to control (150 ppm + 20 µM cisplatin) (n = 3 +SD; *p < 0.05 in DDW and cisplatin-treated cultures in comparison with 150 ppm and 20 µM cisplatin-treated culture)